Health Canada drug identification number

DIN 02247766 — CETROTIDE 0.25 MG

CETROTIDE is a powder for solution of Cetrorelix marketed by EMD SERONO, A DIVISION OF EMD INC., CANADA. The full Cetrorelix monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02247766
Brand name
CETROTIDE
Active ingredient
Cetrorelix
Strength
0.25 MG
Dosage form
POWDER FOR SOLUTION
Route
SUBCUTANEOUS
Manufacturer
EMD SERONO, A DIVISION OF EMD INC., CANADA
Health Canada status
MARKETED
Drug class
Gonadotropin-releasing hormone (GnRH) antagonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.